Company Filing History:
7 out of 441 
2 out of 79 
1 out of 1 Years Active: 1998-2025
Title: Ichiro Watanabe: Innovator in Antibody Therapeutics
Introduction
Ichiro Watanabe is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 8 patents to his name, Watanabe's work has the potential to impact cancer treatment significantly.
Latest Patents
Watanabe's latest patents include groundbreaking inventions such as a bispecific antibody designed to function as an anti-tumor agent. This antibody comprises specific heavy and light chain CDR sequences that enhance its therapeutic efficacy. Another notable invention is the anti-GARP antibody, which binds to GARP and serves as a therapeutic agent for tumors. This antibody inhibits the function of Treg cells in tumors, providing a promising avenue for cancer treatment.
Career Highlights
Throughout his career, Ichiro Watanabe has worked with esteemed organizations, including Daiichi Sankyo Company, Limited and Mie University. His experience in these institutions has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Watanabe has collaborated with notable colleagues such as Toshiaki Ohtsuka and Kazuki Satoh. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Ichiro Watanabe's innovative work in antibody therapeutics showcases his dedication to advancing medical science. His contributions have the potential to lead to significant breakthroughs in cancer treatment, making him a noteworthy figure in the field of biotechnology.